Optimisation of cilnidipine nanoparticles using box-behnken design: in-vitro, toxicity and bioavailability assessment

References

• Krfimer BK, Iussler MH, Ress KM, et al. Renal effects of the new calcium channel blocking drug isradipine. Eur J Clin Pharmacol. 1990;39:333–335.
   PubMed Web of Science ®Google Scholar
• Gidwani B, Vyas A. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology. Artif Cells Nanomed Biotechnol. 2016;44(2):571–580.
   PubMed Web of Science ®Google Scholar
• Venugopal V, Jayaraja Kumar K, Muralidharan S, et al. Optimization and in-vivo evaluation of isradipine nanoparticles using Box-Behnken design surface response methodology. OpenNano. 2016;1:1–15.
   Google Scholar
• Shete M. Cilnidipine: next generation calcium channel blocker. J Assoc Physicians India. 2016;64(4):95–99.
   PubMedGoogle Scholar
• Chandra K, Ramesh G. The fourth-generation calcium channel blocker: cilnidipine. Indian Heart J. 2013;65(6):691–695.
   PubMedGoogle Scholar
• Hu L, Song W, Niu F, et al. Preparation, characterization and tableting of cilnidipine solid dispersions. Pak J Pharm Sci. 2013;26(3):629–636.
   PubMed Web of Science ®Google Scholar
• Diwan R, Ravi PR, Pathare NS, et al. Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. Colloids Surf B Biointerfaces. 2020;193:111073.
   PubMed Web of Science ®Google Scholar
• Mishra R, Mir SR, Amin S. Polymeric nanoparticles for improved bioavailability of cilnidipine. Int J Pharm Pharm Sci. 2017;9(4):129–139.
   Google Scholar
• Tande H, Raval K, Nayani A, et al. Preparation and evaluation of cilnidipine microemulsion. J Pharm Bioallied Sci. 2012;4(1):S114–S115.
   PubMedGoogle Scholar
• Jog R, Burgess D, Pharmaceutical Amorphous J. Nanoparticles. J Pharm Sci. 2017;106:39–65.
   PubMed Web of Science ®Google Scholar
• Cao F, Guo J, Ping Q. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes. Drug Dev Ind Pharm. 2005;31:747–756.
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, et al. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688–1713.
   PubMed Web of Science ®Google Scholar
• Sahu BP, Das MK. Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci. 2014;4:189–197.
   Web of Science ®Google Scholar
• Dalvi SV, Dave RN. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Ind Eng Chem Res. 2009;48:7581–7593+H48.
   Web of Science ®Google Scholar
• Li J, Fu Q, Liu X, et al. Formulation of nimodipine nanocrystals for oral administration. Arch Pharm Res. 2015;39(2):202–212.
   PubMed Web of Science ®Google Scholar
• Karakucuk A, Celebi N. Investigation of formulation and process parameters of wet media milling to develop etodolac nanosuspensions. Pharm Res. 2020;37:111.
   PubMed Web of Science ®Google Scholar
• Panigrahi D, Sahu P, Swain S. Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles. SN Appl Sci. 2021;3:638.
   Google Scholar
• Ali R. Preparation and characterization of dexamethasone polymeric nanoparticle by membrane emulsification method. J Nanopart Res. 2020;22:11.
   Web of Science ®Google Scholar
• Shete PG, Puri V, Kumar L, et al. Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples. AAPS PharmSciTech. 2010;11:598–609.
   PubMed Web of Science ®Google Scholar
• de Almeida M, Da Rocha BA, Francisco CRL, et al. Evaluation of the in vivo acute antiinflammatory response of curcumin-loaded nanoparticles. Food Funct. 2018;24:440–449.
   Google Scholar
• Meng ZX, Xu XX, Zheng W, et al. Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloids Surf B Biointerfaces. 2011;84:97–102.
   PubMed Web of Science ®Google Scholar
• Song Y-J, Wang M, Zhang X-Y, et al. Investigation on the role of the molecular weight of polyvinyl pyrrolidone in the shape control of high-yield silver nanospheres and nanowires. Nanoscale Res Lett. 2014;9(1):17.
   PubMedGoogle Scholar
• Kan-Sen C, Yueh-Sheng L. Effect of polyvinyl pyrrolidone molecular weights on the formation of nanosized silver colloids. Mater Chem Phys. 2004;83:82–88.
   Web of Science ®Google Scholar
• Danyuo Y, Ani CJ, Salifu AA, et al. Anomalous release kinetics of prodigiosin from Poly-N-Isopropyl-Acrylamid based hydrogels for the treatment of triple negative breast cancer. Sci Rep. 2019;9:3862.
   PubMed Web of Science ®Google Scholar
• Karthikeyan M, Deepa MK, Bassim E, et al. Investigation of kinetic drug release characteristics and in vitro evaluation of sustained-release matrix tablets of a selective COX-2 inhibitor for rheumatic diseases. J Pharm Innov. 2020. DOI:10.1007/s12247-020-09459-9.
   Web of Science ®Google Scholar